Thanks for that last link, it was an interesting update on the effectiveness of psychiatry. I was weighting my knowledge of the prevalence of rotten corpses in psychology into my estimate of the effectiveness of psychiatric methods, which now seems to be conflating two very different things. Although it does still seem that the set of psychiatrists who are capable of ignoring the prevalent rotten corpses in psychology when prescribing drugs is still small enough to tip the field toward doing your own analyses. I guess i don’t have a good set of heuristics for comparing the effects of personal bias v the effects of a psychiatrist trained in psychology and prone to that field’s biases.
Yes, my example was loaded. The thought experiment was ‘weird, unrecognized by the system outlier, of personal interest to the reader,’ and whether/in-what-circumstances it should influence the reader to try the drug. If one of those circumstances is ‘pharma doesn’t try to make their drug look effective as a nootropic,’ i feel it sums my perspective a bit better than ‘pharma doesn’t try to make their drug look effective for at least some people, within the set of markets they’ve established as worth aiming marketing toward during a given time period.’
Thanks for that last link, it was an interesting update on the effectiveness of psychiatry. I was weighting my knowledge of the prevalence of rotten corpses in psychology into my estimate of the effectiveness of psychiatric methods, which now seems to be conflating two very different things. Although it does still seem that the set of psychiatrists who are capable of ignoring the prevalent rotten corpses in psychology when prescribing drugs is still small enough to tip the field toward doing your own analyses. I guess i don’t have a good set of heuristics for comparing the effects of personal bias v the effects of a psychiatrist trained in psychology and prone to that field’s biases.
Yes, my example was loaded. The thought experiment was ‘weird, unrecognized by the system outlier, of personal interest to the reader,’ and whether/in-what-circumstances it should influence the reader to try the drug. If one of those circumstances is ‘pharma doesn’t try to make their drug look effective as a nootropic,’ i feel it sums my perspective a bit better than ‘pharma doesn’t try to make their drug look effective for at least some people, within the set of markets they’ve established as worth aiming marketing toward during a given time period.’